|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Deposits and prepaids | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Fixed Assets, Gross | ||||||||||||||||||||
| Website After Deducting Accumulated Amortization | ||||||||||||||||||||
| Patents | ||||||||||||||||||||
| Total Fixed Assets | ||||||||||||||||||||
| Fixed Assets | ||||||||||||||||||||
| Fixed Assets, Gross | ||||||||||||||||||||
| CyberloQ Platform | ||||||||||||||||||||
| Website | ||||||||||||||||||||
| Patent | ||||||||||||||||||||
| Total Fixed Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts Payable and Accrued Expenses | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Note Payable | ||||||||||||||||||||
| Stockholders | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total note Payable | ||||||||||||||||||||
| Adjustment for ASU 2020-06 | ||||||||||||||||||||
| Stockholders | ||||||||||||||||||||
| Total adjustment for ASU 2020-06 | ||||||||||||||||||||
| Loan payable - SBA | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long Term Liabilities | ||||||||||||||||||||
| SBA Loan Payable | ||||||||||||||||||||
| Total Long Term Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Preferred stock, $0.001 par value, 80,000 shares authorized: 29,450 and 20,000 shares issued and outstanding, respectively | ||||||||||||||||||||
| Common stock: $0.001 par value,200,000,000 shares authorized; 141,326,254 and 138,512,256 shares issued and outstanding, respectively | ||||||||||||||||||||
| Treasury stock | ||||||||||||||||||||
| Shares to be issued: Common:1,450,000 and 2,450,000 common shares respectively. Preferred, Series B:5,000 and 0 respectively | ||||||||||||||||||||
| Preferred shares to be issued: 0 and 5,250 | ||||||||||||||||||||
| Common shares to be issued: 1,850,000 and 1,450,000 common shares respectively | ||||||||||||||||||||
| Additional Paid in Capital | ||||||||||||||||||||
| Accumulated Deficit | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||||
Loading...
